YD Bio Ltd (YDES : NASDAQ)
Common Stock
$4.77
USD
+1.54 (47.68%)
Last updated: 2026-09-24
Follow YDES
YDES
YD Bio Ltd
Performance
1 Day
+47.68%
1 Week
+47.22%
1 Month
+1.92%
YTD
+89.29%
Key Statistics
Market Cap
$337.87M
52W High
$22.00
52W Low
$1.70
P/E Ratio
0.00
50 Day MA
$3.23
200 Day MA
$6.31
Beta
-0.03
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $3.26 | $5.41 | $3.26 | $4.77 | $4.77 | 3,124,455 |
| 9/23/2026 | $2.78 | $3.34 | $2.42 | $3.23 | $3.23 | 359,003 |
| 9/22/2026 | $2.67 | $3.10 | $2.60 | $2.82 | $2.82 | 390,344 |
| 9/21/2026 | $3.11 | $3.35 | $2.51 | $2.63 | $2.63 | 662,570 |
| 9/18/2026 | $3.25 | $3.57 | $3.15 | $3.19 | $3.19 | 535,500 |
| 9/17/2026 | $3.70 | $3.76 | $3.12 | $3.24 | $3.24 | 542,641 |
| 9/16/2026 | $3.90 | $3.90 | $3.27 | $3.70 | $3.70 | 695,121 |
| 9/15/2026 | $3.79 | $4.04 | $3.66 | $3.95 | $3.95 | 688,666 |
| 9/14/2026 | $4.01 | $4.01 | $3.61 | $3.83 | $3.83 | 523,342 |
| 9/11/2026 | $3.93 | $4.19 | $3.61 | $4.00 | $4.00 | 819,273 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on YDES's historical volatility
30-Day Vol
206.7%
Annualized
90-Day Vol
164.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$5.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$5.06 | US$2.48 – US$10.33 |
| 60 trading days | US$5.37 | US$1.96 – US$14.73 |
| 90 trading days | US$5.70 | US$1.66 – US$19.61 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About YD Bio Ltd
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue; and LSC Eye Drug/Injection, an injectable ophthalmic drug is being developed for the treatment of various retinal and macular disorders, such as age-related macular degeneration, macular edema, choroidal and subretinal neovascularization, and neovascular glaucoma. It also provides Hydrogel (Hioxifilcon A) Soft (Hydrophilic) Contact Lens, a spherical and aspherical lenses. In addition, the company supplies drugs and medical materials for clinical trials; and operates DNA methylation-based oncology testing programs. Further, it provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination, and compliance-focused support for clinical development programs to pharmaceutical and biotechnology companies. It serves corporate and retail customers. The company was founded in 2013 and is based in Taipei, Taiwan.
Financials
- Revenue (TTM)
- $1.24M
- EBITDA
- $-6.34M
- Profit Margin
- 24.67%
- ROE (TTM)
- -42.69%
- EPS (Diluted)
- 0.00
- Book Value
- 4.57
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About YDES.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |